Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick B Mark

Showing results (161-170 of 238) with videos related to

Pageof 24
Sort By:
European Journal of Heart Failure|January 10, 2025
Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF)Joanna Osmanska, Kieran F Docherty, Colin Berry, et al.
Scientific Reports|October 27, 2017
Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging studyElaine Rutherford, Kenneth Mangion, Christie McComb, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2023
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERAPatrick B Mark, Pantelis Sarafidis, Robert Ekart, et al.
American Heart Journal|February 17, 2024
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and AlbuminuriaHiddo Jl Heerspink, Michele Provenzano, Priya Vart, et al.
Journal of Hypertension|November 7, 2014
Hyperresponders vs. nonresponder patients after renal denervation: do they differ?Alexandre Persu, Michel Azizi, Yu Jin, et al.
Kidney International Reports|January 11, 2021
A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis PatientsElaine Rutherford, Sheila Ireland, Kenneth Mangion, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2024
Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic studyDavid Collister, Lonnie Pyne, Arrti A Bhasin, et al.
Kidney International|August 10, 2016
Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mappingElaine Rutherford, Mohammed A Talle, Kenneth Mangion, et al.
Kidney International Reports|May 2, 2022
Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control StudySara Denicolò, Verena Vogi, Felix Keller, et al.
Clinical Kidney Journal|November 10, 2021
Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohortMichael K Sullivan, Bhautesh Dinesh Jani, Jennifer S Lees, et al.
Pageof 24

Showing results (161-170 of 238) with videos related to

Sort By:
Pageof 24
European Journal of Heart Failure|January 10, 2025
Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF)Joanna Osmanska, Kieran F Docherty, Colin Berry, et al.
Scientific Reports|October 27, 2017
Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging studyElaine Rutherford, Kenneth Mangion, Christie McComb, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2023
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERAPatrick B Mark, Pantelis Sarafidis, Robert Ekart, et al.
American Heart Journal|February 17, 2024
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and AlbuminuriaHiddo Jl Heerspink, Michele Provenzano, Priya Vart, et al.
Journal of Hypertension|November 7, 2014
Hyperresponders vs. nonresponder patients after renal denervation: do they differ?Alexandre Persu, Michel Azizi, Yu Jin, et al.
Kidney International Reports|January 11, 2021
A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis PatientsElaine Rutherford, Sheila Ireland, Kenneth Mangion, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2024
Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic studyDavid Collister, Lonnie Pyne, Arrti A Bhasin, et al.
Kidney International|August 10, 2016
Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mappingElaine Rutherford, Mohammed A Talle, Kenneth Mangion, et al.
Kidney International Reports|May 2, 2022
Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control StudySara Denicolò, Verena Vogi, Felix Keller, et al.
Clinical Kidney Journal|November 10, 2021
Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohortMichael K Sullivan, Bhautesh Dinesh Jani, Jennifer S Lees, et al.
Pageof 24